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Abnormal Coagulation Profiles in Tonsillectomy and Adenoidectomy
Patients
Jonathan L . Schmidt, MD,* Kathleen L . Yaremchuk, MD,* and
Samuel A. Mickelson, MD*

Preoperative coagulation profile screening is routinely performed in otolaryngology before tonsillectomy
and adenoidectomy surgery in the United States. Recently there has been controversy as to whether this
routine testing is necessary. To evaluate the need for this testing, we reviewed a series of patients with
particular attention to abnormal coagulation profiles. Of 91 consecutive patients undergoing
tonsillectomy, adenoidectomy, or both, four had abnormal preoperative coagulation profiles. Of these
patients, one tiad von Wdlebrand disease, one had hypofibrinoginemia, and two had a transient acquired
lupus-like anticoagulant. The latter condition, which causes a temporary prolongation of the activated
partial thromboplastin time, is discussed in detail along with a review ofthe pertinent literature. We
conclude lhal coagulopathies occur frequently enough to justify preoperative screening even in the
absence of a posilive hislory. (Henry Ford Hosp MedJ 1990:38:33-5)

A

pproximately 750,000 adenotonsitlectomies are performed
in the United States annually (1). In this common surgical
procedure the incidence of postoperative hemorrhage ranges
from 0.6% to 7% (2,3). In an effort to reduce this complication,
preoperative determination of the prothrombin time (PT) and the
activated partial thromboplastin time (APTT) has become routine in otolaryngology. Although this preoperative evaluation of
coagulation has been recommended by many authors (4-8), others disagree. They claim that preoperative coagulation testing
has value only when there is a history of abnormal bleeding or
bmising (9-11). However, most of this experience concemed the
general surgical wound, which is primarily closed, and not the
tonsillectomy, which leaves a raw surface to heal by secondary
intention. In our clinic all patients undergoing tonsillectomy
and/or adenoidectomy have PT and APTT determination as part
of their preoperative evaluation. Abnormal values may indicate a
serious coagulopathy or a reversible condition such as an acquired coagulation inhibitor.
Coagulation profiles of 91 consecutive patients undergoing
tonsillectomy, adenoidectomy, or both (all performed by the
same surgeon) were reviewed. Four patients were significantly
abnormal; one had von Willebrand disease, one had hypofibrinoginemia, and two had a transient acquired lupus-Iike
anticoagulant.

formed on an Orthokoagulab I6S, Orthodiagnostics, Raritan,
NJ.) The normal APTT vatue (97.5% ofthe population) is 23 to
36 seconds. Four patients were found to have persistent
abnormalities.

Case Reports
Casel
A 21-year-old female was scheduled for a tonsillectomy for recurrent
tonsillitis. One week priorto surgery PT was 12,0 seconds (control 11,3
seconds) and APTT was 38.5 seconds. Repeated on the morning of surgery, A I ^ T was still abnormal at 40.0 seconds. She had no personal or
family history of bleeding problems and her only current medication
was oral contraceptives (Ortho Novum* 1/35, Ortho Pharmaceutical
Corp, Raritan, NJ),
Three weeks later hematologic investigation disclosed that the APTT
was normal at 35 seconds, but factor VIII antigen and chromogen were
low at 24% (normal 63% to 128%) and 35% (normal 63% to 128%),
respectively. The factor VIII activity was 72% (normal 50% to 200%)
and theristocetinlevel was 25% (normal > 40%), The diagnosis made
was von Willebrand disease. The simplate bleeding time of 14,25 minutes (normal 2,3 to 9,5 minutes) significantly improved to 10.0 minutes
after infusion of 17 |xg of desmopressin (DDAVP).
Accordingly, 17 jig of DDAVP was given one hour before the patient's uneventful tonsillectomy. Preoperative blood loss was 2 mL and
there was no abnormal postoperative bleeding.

Methods and Materials
A total of 91 patients underwent tonsillectomy (31 patients),
adenoidectomy (28 patients), or both (32 patients) by one surgeon (SAM) in 18 months. Routine preoperative hematologic
evaluation included a complete blood count, PT, APTT, and
fibrinogen determination. (Coagulation evaluation was per-
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Case 2
A 16-year-old female was scheduled for tonsillectomy to mie out malignancy as the cause for marked tonsillar asymmetry. In the past she
had experienced significant menorrhagia.
Although PT was 12.0 seconds (control 11.3 seconds) and APTT was
33 seconds, the preoperativefibrinogenlevel was only 140 mg/dL (normal 200 to 400 mg/dL). Repeat PT and APTT were again within normal
limits, investigation for von Willebrand disease was negative (factor
VIII activity 184%, antigen 67%, chromogen 92%, andristocetincofactor level 80%), platelet count was 330,000/|JLL, and thrombin clottingtimewas 8.3 minutes (control 7.3 minutes).
The hematologist suggested the diagnosis of congenital hypofibrinogenemia which had been exacerbated by menorrhagia.
Cryoprecipitate was made available for the procedure but was not required for the uneventful tonsillectomy. Estimated blood loss was 50
mL.
Case 3
A 5-year-old girl presented with tonsillar and adenoidal hypertrophy
and recurrent streptococcal tonsillitis. She had no personal or family
history to suggest a bleeding diathesis.
Tonsillectomy and adenoidectomy were postponed when testing revealed her APTT to be 39.0 seconds. PT was normal at 12.0 seconds
(control 11.5 seconds) andthe von Willebrand tests were normal (factor
VIII activity 95%, antigen 89%, and ristocetin cofactor level 132%), as
was thefibrinogenlevel of 270 mg/dL. The APTT reverted to normal at
33.0 seconds one week later Mixing studies suggested the presence of a
coagulation inhibitor and further evaluation revealed a lupus-like
anticoagulant.
Review of the patient's medical records disclosed that antibiotic
treatment with penicillin, amoxicillin, and cefadroxil had all been administered within the preceding two months for recurrent tonsillitis.
This therapy was associated with the hematologic diagnosis of transient
lupus-like anticoagulant.
The tonsillectomy and adenoidectomy was performed withoul complication. The estimated blood loss was 20 mL.
Case 4
An eight-year-old girl had tonsillar hypertrophy which caused snoring, mouth breathing, and apnea. Preoperative tests disclosed a normal
PT of 12.5 seconds (control 11.7 seconds) but elevated APTT of 39 seconds. This value was confirmed by a repeat test five days later and
APTT remained elevated for the following two months. There was no
personal or family history of any coagulopathy.
The von Willebrand screen was negative, and levels of factors II, IX,
XI, and Xtl were within normal limits. Thefibrinogenlevel was mildly
depressed at 170 mg/dL, and the presence of a mild nonspecific inhibitor of coagulation was demonstrated by mixing studies. Further testing
identified the inhibitor as a lupus-like anticoagulant. The administration of fresh frozen plasma was unnecessary when the tonsillectomy
was performed without incident; estimated blood loss was 5 mL. The
patient had experienced an episode of untreated viral pharyngitis a
month before the first abnormal APTT test.

Discussion
The coagulation process can be arbitrarily divided into four
steps; 1) formation of factor IXa, 2) formation of factor X, 3)
formation of thrombin, and 4) formation of fibrin. Factor X I is
activated by factor Xlla (Hageman factor) and the contact system complex, a reaction which is not calcium dependent. Factor
IX is activated by factor XIa in the presence of calcium. Factor X
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is activated by two mechanisms; 1) factor Vtt, in the presence of
tissue thromboplastin released from damaged vascular tissue,
converts factor X to factor Xa in a calcium-dependent reaction;
and 2) factor tXa in the presence of factor VIII and calcium may
atso activate factor X. This complex, factor IXa-Vlll-calcium-X
is bound to platelet lipid mycetles.
The conversion of prothrombin to thrombin is achieved by
factor Xa in a complex with factor V and calcium. Binding of
factor V to the platelet membrane is critical to the reaction.
Thrombin, the enzyme derived from prothrombin, cleaves
fibrinopeptides AB from the A^, and Bg chains of the fibrinogen
molecule. The remaining major portion of the molecule, fibrin
monomer, polymerizes to form fibrin. This polymer is stabilized
by factor XIII through conversion of weatc hydrogen bonds to
stable covalent bonds. The actions of thrombin and platelet factor XUI are calcium dependent.
For practical purposes the coagulation cascade has been divided into two pathways; the intrinsic system representing the
pathway used in the absence of tissue extract, and the extrinsic
system representing the pathway used in the presence of tissue
juices. The concept of two pathways, although not strictly factual, has proved valuable for the study of blood coagulation and
the laboratory investigation of clotting disorders. A defect in the
intrinsic pathway usually causes a prolongation of APTT and a
defect in the extrinsic pathway causes a prolongation of the PT.
Prolonged APTT and/or PT is usually caused either by deficiency of one or more coagulation factors or by the presence of a
circularing inhibitor of the clotting system. Circulating anticoagulants or inhibitors of clotting factors are substances produced endogenously which affect various in vitro tests of
coagulation.
In the present series, four (5%) of 91 consecutive patients undergoing tonsillectomy and/or adenoidectomy by one surgeon
were found to have abnormalities of coagulation. One patient
had von Willebrand disease, one had congenital hypofibrinogenemia, and two had acquired, transient lupus-like inhibitors. The von Willebrand disease and hypofibrinogenemia
have been well discussed in the literature (12) but acquired inhibitors of coagulation may not be familiar to surgeons.
There are two types of acquired inhibitors; blocking inhibitors, and specific factor depressants. Blocking inhibitors are
usually proteins which interfere with an entire coagulation reaction but are seldom responsible for clinical bleeding (13). Blocking inhibitors occur in systemic lupus erythematosus, collagen
vascular diseases, malignancies, viral infections, or following
exposure to certain dmgs such as penicillin and/or its derivatives
(14-16). Specific factor depressants inactivate a certain clotting
factor. Inhibitors against factors V, V I I I , I X , X I , and XIII have
been described, with factor VIII inhibitors being the most common (13,16-18). Specific factor depressants are usually antibodies and can be responsible for severe bleeding. Specific factor depressants occur in postpartum women, autoimmune
disorders such as rheumatoid arthritis, and in dermatologic
problems such as psoriasis and pemphigus. Coagulation tests
(PT or APTT) may be prolonged either by inhibitors or by factor
deficiencies. To differentiate the presence of inhibitors from
specific factor deficiencies, mixing studies are performed.
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When mixing one-part patient plasma with one-part normal
plasma fails to correct the prolonged PT or APTT, the diagnosis
of circulating inhibitor is considered to be established.
The most common explanation of the development of blocking inhibitors in otherwise healthy children is the exposure to
either penicillin and its derivatives or the presence of viral infection (13,19). Our series provides an example of each.
Orris et al (13) investigated 13 children with abnormal APTTs
and discovered that all had recently received penicillin or a derivative. The one child who had clinical bleeding developed petechiae and was found to have thrombocytopenia. All 13 patients
had transient blocking inhibitors. Ten of these patients subsequently underwent surgical procedures (one for excision of an
infected thyroglossal duct cyst and the remainder for tonsillectomy) after the blocking inhibitors disappeared and coagulation
studies had returned to normal. No bleeding complicarions
occurred.
Other authors correlated recent viral infections with the development of protonged APTT. Vimses thought to be involved
inctude Epstein-Barr, adenovims, cytomegalovims, and infectious mononucleosis. Development of circulating coagulation
inhibitors by other mechanisms may be analogous to the occurrence of idiopathic thrombocytopenic purpura after a viral infection which is thought to cause the devetopment of antibodies to
the platelet membrane. In the latter disorder the antibodies usually disappear spontaneously within two months.
The occurrence of acquired inhibitors of coagulation may be
more common than is indicated by the medical literature (19).
Because of the transient nature of the inhibitors and their usual
lack of clinical consequences, their presence is usually discovered only by routine preoperative screening. Patients who
have viral infections or who have received penicillin recently are
frequently encountered in otolaryngology. Whenever an abnormal coagulation test result is identified, even a minor one, the
test must be repeated, and if the abnormality persists hematologic consultation is necessary. Screening tests do not differentiate a mild from a potentially serious coagulopathy (12). A
result just out of the normal range may in fact be a clue to a hematologic disorder that could lead to disastrous complications of
a surgical procedure.
In this series of just 94 patients, two potentially serious disorders were discovered. Tonsillectomy and adenoidectomy differs
from other surgical procedures in that it leaves an open wound to
heal by secondary intention over two weeks. Even normal patients may have significant postoperative bleeding and those
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with bleeding disorders must be identified. Transient lupus-like
anficoagulants, which cause an elevation of the APTT, can be
differentiated from serious coagulopathies onty by further hematologic testing. If only a transient inhibitor is identified, the
surgical procedure can be safety performed when the APTT has
retumed to normal.
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